Searched for
DRUG PATENT EXPIRATION
Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
- If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...
- Profit on paper, loss in reality: How a routine accounting tool is used to deceive and take investors for a rideAmortisation is a number most investors skip, but it can shape reported profit. On the surface, it looks routine: A company spreads the cos...
- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- Hindustan Labs, RK Steel get Sebi nod to launch IPOsHindustan Laboratories has received Sebi's observations, a crucial step towards its IPO, which includes a fresh issue and an offer for sale...
- Alkem Labs CEO Vikas Gupta may exit companyAlkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...
- Weight-loss drug craze for Ozempic, Mounjaro surges in India amid safety concernsIn India, appetite for weight-loss drugs is on the rise, with consumers increasingly turning to injectables such as Mounjaro and Ozempic fo...
- Semaglutide API price plunges amid GLP-1 rushGlobal demand for weight-loss drugs Ozempic and Wegovy has caused semaglutide prices to drop significantly. Manufacturing has expanded rapi...
- Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- Patent cliff can turn Indian pharma stocks into investor’s goldminePharma stocks have surged due to a 'Patent Cliff,' where numerous drug patents expire, allowing generic manufacturers, especially in India,...
- Pfizer moves US court against Aurobindo Pharma, Dr Reddy's on cancer drugIn March 2019, several generic companies notified us that they had filed abbreviated new drug applications with the US Food and Drug Admini...
- Dr Reddy's sued for 'infringement' of thyroid injection patentUS-based drug maker AbbVie Inc has dragged Dr Reddy's Lab to court for allegedly infringing the former's patented drug Zemplar on six count...
- Sun Pharma takes Novartis to US Court, seeks permission to market Glivec in USUntil and unless Sun obtains a court decision of non-infringement and/or invalidity on the ’051 patent, it faces the risk of patent infring...
- Fresenius files patent infringements suit against DRL in USFresenius Kabi has dragged leading pharmaceuticals company Dr Reddy's to court for allegedly infringing on the former's patented anaestheti...
- Sun Pharma gets FDA nod for generic version of JanuviaThis comes as a surprise as Sun has partnered the US based MSD in the domestic market to sue Glenmark for the patent infringement on the sa...
- Dr Reddy's Laboratories wins round 1 of patent warUS court dismisses one of the three patent claims made by Roche for Boniva; DRL still in litigation for two other listed patents.
Load More
